Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346214 · ClinicalTrials.gov registry record
Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age
A clinical trial, sponsored by RTI International.
- Completed
- Registry status
- 252
- Enrollment target
NCT02346214 is a clinical trial that has completed, run by RTI International. The registered enrollment target is 252 participants.
The verdict
NCT02346214 has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a novel, highly automated method of gestational age estimation at delivery combining anterior lens capsule vascularity (ALCV) and biophysical parameters appropriate for use in low income countries. The specific aims of the proposed study are: (1) To develop an algorithm to predict gestational age at delivery from 26 to 42 weeks' gestation with ALCV and key biophysical parameters (2)To evaluate the performance of ALCV and biophysical parameter-based gestational age estimates. Specifically, we hypothesize that the accuracy of the predictive algorithm will be comparable to commonly used measures of gestational age dating (±2 days) and have better precision (±14 days) than commonly used measures of gestational age dating.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02346214
The ClinicalTrials.gov registry entry for NCT02346214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02346214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02346214 about?
NCT02346214 is a clinical study titled "Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age". The purpose of this study is to develop a novel, highly automated method of gestational age estimation at delivery combining anterior lens capsule vascularity (ALCV) and biophysical parameters appropriate for use in low income countries. The specific aims of the proposed study are: (1) To develop an...
What is the current status of trial NCT02346214?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2016-07. Estimated completion is 2017-11-30.
Who is sponsoring clinical trial NCT02346214?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.